Net profit of Gujarat Terce Laboratories declined 24.75% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 1.01 crore during the previous quarter ended December 2024. Sales declined 3.08% to Rs 12.29 crore in the quarter ended December 2025 as against Rs 12.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales12.2912.68 -3 OPM %9.288.60 - PBDT1.231.08 14 PBT1.130.98 15 NP0.761.01 -25 Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live News

Net profit of Gujarat Terce Laboratories declined 5.41% to Rs 1.40 crore in the quarter ended September 2025 as against Rs 1.48 crore during the previous quarter ended September 2024. Sales declined 2.78% to Rs 12.93 crore in the quarter ended September 2025 as against Rs 13.30 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales12.9313.30 -3 OPM %14.6212.41 - PBDT1.881.60 18 PBT1.781.51 18 NP1.401.48 -5 Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live News

Net Loss of Gujarat Terce Laboratories reported to Rs 0.04 crore in the quarter ended June 2025 as against net loss of Rs 0.08 crore during the previous quarter ended June 2024. Sales declined 8.75% to Rs 10.85 crore in the quarter ended June 2025 as against Rs 11.89 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales10.8511.89 -9 OPM %-0.090.67 - PBDT0.030.02 50 PBT-0.07-0.07 0 NP-0.04-0.08 50 Powered by Capital Market - Live News